Tremfya 200 mg concentrate for solution for infusion | medicines.ie

Company: Janssen Sciences Ireland (a Johnson & Johnson Company)
Active Ingredient: Guselkumab
Dosage Form: Concentrate for solution for infusion
Legal Category: –
Date of revision: 03/2026

*Additional information is available within the SPC or upon request to the company

Loading the document

Janssen Sciences Ireland (a Johnson & Johnson Company)

Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46, P43 FA46 Ringaskiddy

Website: https://innovativemedicine.jnj.com/ireland/
Telephone: +3531800709122
Email: medinfo@its.jnj.com